Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland

被引：0
|
作者：
Peter Wiesli
Marcus Schories
机构：
[1] FMH Endokrinologie/Diabetologie,
[2] Kantonsspital Frauenfeld,undefined
[3] FMH Endokrinologie/Diabetologie,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Insulin glargine 300 U/mL; Real-world; Switzerland; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2325 / 2334
页数：9
相关论文
共 50 条
  • [1] Improved Glycemic Control with Insulin Glargine 300U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland
    Wiesli, Peter
    Schories, Marcus
    [J]. DIABETES THERAPY, 2018, 9 (06) : 2325 - 2334
  • [2] The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in Israel
    Cohen, Cheli Melzer
    Banon, Tamar
    Shalev, Varda
    Chodick, Gabriel
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (03)
  • [3] Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes
    Paola, Lucidi
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    [J]. DIABETES, 2020, 69
  • [4] The effectiveness of insulin glargine 300 U/ml among type 2 diabetes patients: analysis of a real world data
    Cohen, C. Melzer
    Shalev, V.
    Chodick, G.
    [J]. DIABETOLOGIA, 2019, 62 : S436 - S437
  • [5] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    [J]. DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [6] Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
    Thomann, Robert
    Zechmann, Stefan
    Alexander-David, Nicola
    Jornayvaz, Francois R.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 2359 - 2365
  • [7] Improved real-world outcomes for type 2 diabetes patients on basal-bolus insulin therapy switching to insulin glargine 300 U/ml vs. insulin glargine 100 U/ml and insulin Detemir
    Wu, Jasmanda
    Bailey, Timothy S.
    Bosnyak, Zsolt
    Westerbacka, Jukka
    Gupta, Rishab A.
    Menon, Arjun A.
    Nicholls, Charlie
    Blonde, Lawrence
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 416 - 417
  • [8] LONGITUDINAL ANALYSIS OF REAL-WORLD BASAL INSULIN UTILIZATION FOR TYPE I AND TYPE II DIABETES PATIENTS SWITCHING TO INSULIN GLARGINE U-300 (TOUJEO®)
    Zhang, Yvonne
    Sauriol, Luc
    Glass, Jennifer
    Millson, Brad
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S242 - S242
  • [9] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
    Gagik R. Galstyan
    Amir Tirosh
    Hernando Vargas-Uricoechea
    Maria Aileen Mabunay
    Mathieu Coudert
    Mubarak Naqvi
    Valerie Pilorget
    Niaz Khan
    [J]. Diabetes Therapy, 2022, 13 : 1187 - 1202
  • [10] Effectiveness and safety of insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes after failure of oral therapy in a real-world setting
    Pfohl, Martin
    Jornayvaz, Francois R.
    Fritsche, Andreas
    Pscherer, Stefan
    Anderten, Helmut
    Pegelow, Katrin
    Seufert, Jochen
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (05): : 759 - 766
12345